In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance

Affiliations

• ¹ Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland.
• ² Regional Service of the Swiss Red Cross, University Hospital Basel, Switzerland.
• ³ Internal Medicine, Cantonal Hospital of Baden, Switzerland.
• ⁴ Hematology, University Hospital Basel, Switzerland.
• ⁵ Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland juerg-hans.beer@ksb.ch.